Infection Control for Safe Environments

A seasoned CEO and senior executive with a record of achievement in sales, marketing and operations development, strategic planning, and business development. Mr. Saeed recently was CEO of Ubiquity LLC and advised the National Mental Health Innovation Center (NMHIC), worked with CU Innovations on business partnerships and co development with their technology innovation network (TIN) on virtual and augmented reality to conduct interventions and training protocols at the University of Colorado Anschutz Medical Center.

Previously, in 2016 he was founder and CEO of Vital Neuro, Inc. which has converged machine learning and cloud technologies in a closed feedback system. Vital Neuro is an evidence based, proven service relieving employee stress with a personalized 15 minute daily sessions through an connected app.

Prior to that and until the end of 2015 Mr. Saeed spent three and a half years at Kymeta Corporation, a Bill Gates company, as the EVP of strategy and development creating a market approach to the connected car strategy, sourcing and securing unique raw materials and industry relations and partnerships.

Among several smaller startups, Mr. Saeed Co-founded Open Range Communications in 2004 to deliver broadband to rural and underserved communities in the US. In 2001 Mr. Saeed was instrumental in the launch of the first cellular Blackberry at T-Mobile USA where he was part of the pioneering team introducing the first device converging voice and data to the market in 2001. He worked at AT&T wireless advanced services organization introducing CDPD and converged wireless data through 1999.

Most recently, Mr. Doyle was the President of Panasonic Enterprise Solutions company, a $450 million solution and engineering company focused primarily on North America, but with limited clients in Asia and Europe. This company built complex solutions for Panasonic’s global customers in sports and entertainment, energy, and smart city industries. His clients ranged from the Philadelphia Eagles to MGM to the US Government.

Before joining Panasonic, Mr. Doyle was a Consulting Partner with IBM Global Business Services leading its North American Electronics industry solutions unit, the final role in a thirteen-year span with IBM.

Mr. Doyle currently serves on the board of Mobilitynext, a nonprofit organization that brings public and private entities together to solve the world’s most challenging transportation and mobility challenges.

Mr. Doyle also served as an Officer in the US Marine Corps, participating in Operation Restore Hope in Somalia. Mr. Doyle has an MBA in Marketing and Decision & Information Systems from Indiana University and a BS in Marketing from Syracuse University.

Mr. Riccio joins Applied UV with broad experience in corporate and operational finance, most recently as Chief Financial Officer & Treasurer of Panasonic Corporation of North America, leading the finance organization that supports the principal North American subsidiary of Osaka, Japan-based Panasonic Corporation. Throughout his career at the Panasonic subsidiary, he demonstrated a track record as a results-oriented leader with a strong record of improving financial performance across a variety of sectors, including consumer, systems and solutions, and industry. Working with other executives, Mr. Riccio was part of the team that defined and implemented strategies driving significant growth of Panasonic North America revenue.

He joined Panasonic in October 1986 from Sealed Air Corporation, where he  was the Corporate Accounting Manager. Prior to Sealed Air, Mr. Riccio was a Senior Auditor at CohnReznick. Mr. Riccio is a Certified Public Accountant (CPA) and holds a B.A. in accounting from Rutgers University and an MBA in finance from Rutgers Business School.

She was most recently head of Corporate Development at Terumo BCT, the $1 billion biomedical division of Terumo Corporation (4543.T-JP:TokyoSE), with responsibility for partnerships to augment the division’s products and technologies for life-saving blood and cell-based therapies.

Previously she served as Chief Operating Officer of Andarix Pharmaceuticals, a clinical stage oncology therapeutics company, and President/CEO of Caveo Therapeutics, a biotechnology company with reagent and therapeutic antibody product lines. In consulting roles with Cygnet Venture Management, she served as interim management for senior level business development and marketing functions, working with life science CEOs and founders and helping clients raise over $30M.

Ms. Wallen was formerly an investment professional with Sequel Venture Partners and is a Director of Ekso Bionics (Nasdaq: EKSO), and Boulder Community Health.